• Guillermo Kohn-Loncarica, Gabriela Hualde, Ana Fustiñana, María Fernanda Monticelli, Graciela Reinoso, Miguel Cortéz, Leonardo Segovia, Gustavo Mareco-Naccarato, and Pedro Rino.
• Pediatr Emerg Care. 2022 Jan 1; 38 (1): e371e377e371-e377.

ObjectiveMortality in pediatric septic shock remains unacceptably high. Delays in vasopressor administration have been associated with an increased risk of mortality. Current treatment guidelines suggest the use of a peripheral vascular line (PVL) for inotropic administration in fluid-refractory septic shock when a central vascular line is not already in place. The aim of this study was to report local adverse effects associated with inotropic drug administration through a PVL at a pediatric emergency department setting in the first hour of treatment of septic shock.MethodsA prospective, descriptive, observational cohort study of patients with septic shock requiring PVL inotropic administration was conducted at the pediatric emergency department of a tertiary care pediatric hospital. For the infusion and postplacement care of the PVL for vasoactive drugs, an institutional nursing protocol was used.ResultsWe included 49 patients; 51% had an underlying disease. Eighty-four percent of the children included had a clinical "cold shock." The most frequently used vasoactive drug was epinephrine (72%). One patient presented with local complications.ConclusionsAt our center, infusion of vasoactive drugs through a PVL was shown to be safe and allowed for adherence to the current guidelines for pediatric septic shock.Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

11 keywords...

hide…